More than 200 employees at Perrigo’s Bronx plant have been on strike since September 2, as the company seeks to expand its operations to a seven-day workweek. This strategic shift highlights Perrigo’s commitment to increasing production capacity in a competitive market.
The strike underscores the tension between labor and management, especially as Perrigo navigates the complexities of scaling operations while maintaining workforce stability. The company’s decision to replace striking workers suggests a significant pivot in its approach to labor relations, potentially impacting its reputation and operational dynamics in the long term.
As the pharmaceutical industry faces ongoing supply chain challenges, Perrigo’s actions may set a precedent for how companies manage workforce disputes during periods of operational expansion. Stakeholders in regulatory, QA/QC, CMC, and sourcing roles should closely monitor this situation, as it may influence labor practices and operational strategies across the sector.
